MDxHealth Statistics
Total Valuation
MDxHealth has a market cap or net worth of $113.35 million. The enterprise value is $131.65 million.
Important Dates
The next estimated earnings date is Wednesday, August 20, 2025, after market close.
| Earnings Date | Aug 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 49.50 million shares outstanding. The number of shares has increased by 39.86% in one year.
| Current Share Class | 49.50M |
| Shares Outstanding | 49.50M |
| Shares Change (YoY) | +39.86% |
| Shares Change (QoQ) | -0.81% |
| Owned by Insiders (%) | 9.21% |
| Owned by Institutions (%) | 22.89% |
| Float | 35.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.82 |
| Forward PS | 0.97 |
| PB Ratio | 16.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 14.07.
| Current Ratio | 2.00 |
| Quick Ratio | 1.88 |
| Debt / Equity | 14.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.38 |
Financial Efficiency
Return on equity (ROE) is -1,552.23% and return on invested capital (ROIC) is -21.82%.
| Return on Equity (ROE) | -1,552.23% |
| Return on Assets (ROA) | -9.57% |
| Return on Invested Capital (ROIC) | -21.82% |
| Return on Capital Employed (ROCE) | -17.24% |
| Revenue Per Employee | $302,907 |
| Profits Per Employee | -$124,253 |
| Employee Count | 312 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 11.28 |
Taxes
In the past 12 months, MDxHealth has paid $519,000 in taxes.
| Income Tax | 519,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.29% in the last 52 weeks. The beta is -490,509.46, so MDxHealth's price volatility has been lower than the market average.
| Beta (5Y) | -490,509.46 |
| 52-Week Price Change | -7.29% |
| 50-Day Moving Average | 1.95 |
| 200-Day Moving Average | 1.95 |
| Relative Strength Index (RSI) | 64.01 |
| Average Volume (20 Days) | 70,630 |
Short Selling Information
| Short Interest | 41,354 |
| Short Previous Month | 41,102 |
| Short % of Shares Out | 0.10% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.53 |
Income Statement
In the last 12 months, MDxHealth had revenue of $94.51 million and -$38.77 million in losses. Loss per share was -$1.02.
| Revenue | 94.51M |
| Gross Profit | 58.58M |
| Operating Income | -22.71M |
| Pretax Income | -39.90M |
| Net Income | -38.77M |
| EBITDA | -16.59M |
| EBIT | -22.71M |
| Loss Per Share | -$1.02 |
Full Income StatementBalance Sheet
The company has $65.67 million in cash and $83.98 million in debt, giving a net cash position of -$18.31 million or -$0.37 per share.
| Cash & Cash Equivalents | 65.67M |
| Total Debt | 83.98M |
| Net Cash | -18.31M |
| Net Cash Per Share | -$0.37 |
| Equity (Book Value) | 5.97M |
| Book Value Per Share | 0.12 |
| Working Capital | 43.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.65 million and capital expenditures -$1.44 million, giving a free cash flow of -$17.09 million.
| Operating Cash Flow | -15.65M |
| Capital Expenditures | -1.44M |
| Free Cash Flow | -17.09M |
| FCF Per Share | -$0.35 |
Full Cash Flow StatementMargins
Gross margin is 61.99%, with operating and profit margins of -24.03% and -41.02%.
| Gross Margin | 61.99% |
| Operating Margin | -24.03% |
| Pretax Margin | -40.47% |
| Profit Margin | -41.02% |
| EBITDA Margin | -17.56% |
| EBIT Margin | -24.03% |
| FCF Margin | n/a |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.86% |
| Shareholder Yield | -39.86% |
| Earnings Yield | -34.20% |
| FCF Yield | -15.08% |
Analyst Forecast
The average price target for MDxHealth is $6.00, which is 162.01% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 162.01% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 19.80% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
MDxHealth has an Altman Z-Score of -2.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.33 |
| Piotroski F-Score | 3 |